Caenorhabditis elegans: A useful tool to decipher neurodegenerative pathways

Biochemical Society Transactions

Volumn 38, Issue 2, 2010, Pages 559-563

  Johnson, James R ^a   Jenn, Robert C ^a   Barclay, Jeff W ^a   Burgoyne, Robert D ^a   Morgan, Alan ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Caenorhabditis elegans; Cysteine string protein (CSP); Genetic screen; Neurodegeneration; RNA interference (RNAi)

Indexed keywords

POLYGLUTAMINE;

CAENORHABDITIS ELEGANS; DEGENERATIVE DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TAUOPATHY; ANIMAL; ANIMAL MODEL; GENETICS; HUMAN; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CAENORHABDITIS ELEGANS; INVERTEBRATA; MAMMALIA;

ANIMALS; CAENORHABDITIS ELEGANS; HUMANS; MODELS, ANIMAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION; TAUOPATHIES;

EID: 77953250088     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380559     Document Type: Review

References (47)

1. Skovronsky, D.M., Lee, V.M. and Trojanowski, J.Q. (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151-170
2. Gibb, W.R., Esiri, M.M. and Lees, A.J. (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110, 1131-1153 (Pubitemid 17167996)
3. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840
4. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047 (Pubitemid 27443610)
5. Chartier-Harlin, M.C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M. et al. (2004) α-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169
6. Kosik, K.S., Joachim, C.L. and Selkoe, D.J. (1986) Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044-4048
7. Glenner, G.G., Wong, C.W., Quaranta, V. and Eanes, E.D. (1984) The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl. Pathol. 2, 357-369
8. Lee, V.M., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159
9. Ingram, E.M. and Spillantini, M.G. (2002) Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8, 555-562
10. Zoghbi, H.Y. and Orr, H.T. (2000) Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217-247
11. Gidalevitz, T., Ben-Zvi, A., Ho, K.H., Brignull, H.R. and Morimoto, R.I. (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311, 1471-1474 (Pubitemid 43376703)
12. Winderickx, J., Delay, C., De Vos, A., Klinger, H., Pellens, K., Vanhelmont, T., Van Leuven, F. and Zabrocki, P. (2008) Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim. Biophys. Acta 1783, 1381-1395
13. Falkenburger, B.H. and Schulz, J.B. (2006) Limitations of cellular models in Parkinson's disease research, J. Neural Transm. Suppl., 261-268
14. Hall, G.F. and Yao, J. (2005) Modeling tauopathy: a range of complementary approaches. Biochim. Biophys. Acta 1739, 224-239
15. Brenner, S. (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94
16. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811
17. White, J.G., Southgate, E., Thompson, J.N. and Brenner, S. (1986) The structure of the nervous system of the nematode Caenorhabditis elegans. Philos. Trans. R. Soc. London Ser. B 314, 1-340
18. White, J.G., Southgate, E., Thomson, J.N. and Brenner, S. (1976) The structure of the ventral nerve cord of Caenorhabditis elegans. Philos. Trans. R. Soc. London Ser. B 275, 327-348
19. Sulston, J., Dew, M. and Brenner, S. (1975) Dopaminergic neurons in the nematode Caenorhabditis elegans. J. Comp. Neurol. 163, 215-226
20. Wittenburg, N., Eimer, S., Lakowski, B., Rohrig, S., Rudolph, C. and Baumeister, R. (2000) Presenilin is required for proper morphology and function of neurons in C. elegans. Nature 406, 306-309 (Pubitemid 30604408)
21. Gengyo-Ando, K., Kitayama, H., Mukaida, M. and Ikawa, Y. (1996) A murine neural-specific homolog corrects cholinergic defects in Caenorhabditis elegans unc-18 mutants. J. Neurosci. 16, 6695-6702
22. Graham, M.E., Edwards, M.R., Holden-Dye, L., Morgan, A., Burgoyne, R.D. and Barclay, J.W. (2009) UNC-18 modulates ethanol sensitivity in Caenorhabditis elegans. Mol. Biol. Cell 20, 43-55
23. Johnson, J.R., Ferdek, P., Lian, L.Y., Barclay, J.W., Burgoyne, R.D. and Morgan, A. (2009) Binding of UNC-18 to the N-terminus of syntaxin is essential for neurotransmission in Caenorhabditis elegans. Biochem. J. 418, 73-80
24. Kraemer, B.C., Zhang, B., Leverenz, J.B., Thomas, J.H., Trojanowski, J.Q. and Schellenberg, G.D. (2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. U.S.A. 100, 9980-9985
25. Asikainen, S., Vartiainen, S., Lakso, M., Nass, R. and Wong, G. (2005) Selective sensitivity of Caenorhabditis elegans neurons to RNA interference. NeuroReport 16, 1995-1999
26. Guthrie, C.R., Schellenberg, G.D. and Kraemer, B.C. (2009) SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum. Mol. Genet. 18, 1825-1838
27. Kraemer, B.C. and Schellenberg, G.D. (2007) SUT-1 enables tau-induced neurotoxicity in C. elegans. Hum. Mol. Genet. 16, 1959-1971
28. Schmidt, E., Seifert, M. and Baumeister, R. (2007) Caenorhabditis elegans as a model system for Parkinson's disease. Neurodegener. Dis. 4, 199-217
29. Kuwahara, T., Koyama, A., Gengyo-Ando, K., Masuda, M., Kowa, H., Tsunoda, M., Mitani, S. and Iwatsubo, T. (2006) Familial Parkinson mutant α-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans. J. Biol. Chem. 281, 334-340
30. Lakso, M., Vartiainen, S., Moilanen, A.M., Sirvio, J., Thomas, J.H., Nass, R., Blakely, R.D. and Wong, G. (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α-synuclein. J. Neurochem. 86, 165-172 (Pubitemid 36753857)
31. Vartiainen, S., Pehkonen, P., Lakso, M., Nass, R. and Wong, G. (2006) Identification of gene expression changes in transgenic C. elegans overexpressing human α-synuclein. Neurobiol. Dis. 22, 477-486 (Pubitemid 43832121)
32. Cooper, A.A., Gitler, A.D., Cashikar, A., Haynes, C.M., Hill, K.J., Bhullar, B., Liu, K., Xu, K., Strathearn, K.E., Liu, F. et al. (2006) α-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328
33. van Ham, T.J., Thijssen, K.L., Breitling, R., Hofstra, R.M., Plasterk, R.H. and Nollen, E.A. (2008) C. elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging. PLoS Genet. 4, e1000027
34. Hamamichi, S., Rivas, R.N., Knight, A.L., Cao, S., Caldwell, K.A. and Caldwell, G.A. (2008) Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc. Natl. Acad. Sci. U.S.A. 105, 728-733
35. Kuwahara, T., Koyama, A., Koyama, S., Yoshina, S., Ren, C.H., Kato, T., Mitani, S. and Iwatsubo, T. (2008) A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in α-synuclein transgenic C. elegans. Hum. Mol. Genet. 17, 2997-3009
36. Faber, P.W., Voisine, C., King, D.C., Bates, E.A. and Hart, A.C. (2002) Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99, 17131-17136
37. Nollen, E.A., Garcia, S.M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R.I. and Plasterk, R.H. (2004) Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl. Acad. Sci. U.S.A. 101, 6403-6408
38. Lee, J., Nam, S., Hwang, S.B., Hong, M., Kwon, J.Y., Joeng, K.S., Im, S.H., Shim, J. and Park, M.C. (2004) Functional genomic approaches using the nematode Caenorhabditis elegans as a model system. J. Biochem. Mol. Biol. 37, 107-113
39. Link, C.D. (2006) C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease. Exp. Gerontol. 41, 1007-1013
40. Morcos, M. and Hutter, H. (2009) The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease. J. Alzheimers Dis. 16, 897-908
41. Prahlad, V. and Morimoto, R.I. (2009) Integrating the stress response: lessons for neurodegenerative diseases from C. elegans. Trends Cell Biol. 19, 52-61
42. Fernandez-Chacon, R., Wolfel, M., Nishimune, H., Tabares, L., Schmitz, F., Castellano-Munoz, M., Rosenmund, C., Montesinos, M.L., Sanes, J.R., Schneggenburger, R. and Südhof, T.C. (2004) The synaptic vesicle protein CSPα prevents presynaptic degeneration. Neuron 42, 237-251
43. Umbach, J.A., Zinsmaier, K.E., Eberle, K.K., Buchner, E., Benzer, S. and Gundersen, C.B. (1994) Presynaptic dysfunction in Drosophila csp mutants. Neuron 13, 899-907
44. Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O.M. and Südhof, T.C. (2005) α-Synuclein cooperates with CSPα in preventing neurodegeneration. Cell 123, 383-396
45. Chamberlain, L.H. and Burgoyne, R.D. (1997) Activation of the ATPase activity of heat-shock proteins Hsc70/Hsp70 by cysteine-string protein. Biochem. J. 322, 853-858
46. Chamberlain, L.H. and Burgoyne, R.D. (1998) The cysteine-string domain of the secretory vesicle cysteine-string protein is required for membrane targeting. Biochem. J. 335, 205-209
47. Chamberlain, L.H. and Burgoyne, R.D. (2000) Cysteine-string protein: the chaperone at the synapse. J. Neurochem. 74, 1781-1789